3 completed, 1 active not recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow DNA methylation analysis: new trials by email Literature Review of DNA methylation analysis trials Research Report on DNA methylation analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab and Lomustine for Recurrent GBM bevacizumab, lomustine, DNA methylation analysis - Glioblastoma Multiforme, Cognition Disorders | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 592 | 2011-10-01 | 2021-02-15 |
| Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) temozolomide, DNA methylation analysis, laboratory biomarker analysis - Brain and Central Nervous System Tumors | Phase 3 | Active not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 751 | 2007-12-01 | 2023-09-11 |
| Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme temozolomide, DNA methylation analysis, quality-of-life assessment - Brain and Central Nervous System Tumors | Phase 3 | Completed | Canadian Cancer Trials Group | 562 | 2007-11-14 | 2023-08-22 |
| Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes alemtuzumab, arsenic trioxide, azacitidine - Leukemia, Myelodysplastic Syndromes | Phase 2 / Phase 3 | Completed | The University of New South Wales | 2000 | 2006-08-01 | 2013-08-26 |
Central Nervous System Neoplasms (2) · Glioblastoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Astrocytoma (1) · Brain Neoplasms (1) · Cognition Disorders (1) · Congenital Abnormalities (1) · Gliosarcoma (1) · Leukemia (1) · Leukemia, Basophilic, Acute (1) · Leukemia, Eosinophilic, Acute (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1)
European Organisation for Research and Treatment of Cancer - EORTC (2) · Canadian Cancer Trials Group (1) · The University of New South Wales (1)
Netherlands (3) · Canada (2) · Germany (2) · United Kingdom (2) · Australia (1) · Belgium (1) · France (1) · Israel (1) · Italy (1) · Japan (1) · Spain (1) · Switzerland (1) · United States (1)
Alan K. Burnett, MD, FRCP (1) · Alba A. Brandes, MD (1) · Anna Nowak, MD (1) · James R. Perry, MD, FRCPC (1) · Johan Menten, MD, PhD (1) · Michael A. Vogelbaum, MD, PhD (1) · Normand Laperriere, MD, FRCPC (1) · S. Erridge (1) · Warren P. Mason, MD (1) · Wolfgang Wick (1) · Wolfgang Wick, Pr. (1)
PMID 24117272, PMID 27744512, PMID 28296618, PMID 28801186, PMID 29141164, PMID 32632894, PMID 34000245, PMID 35275197, PMID 41449147